Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.
Bioorg Med Chem Lett
; 15(15): 3568-72, 2005 Aug 01.
Article
em En
| MEDLINE
| ID: mdl-15982878
ABSTRACT
The novel immunosuppressant FTY720 has been demonstrated to elicit immunomodulating effects via interaction with the G-protein coupled receptor S1P(1). FTY720 induced agonism at the S1P(3) receptor, however, has been shown to result in mild bradycardia, a minor side-effect of initial FTY720 therapy. This report describes the synthesis of several potent 4(5)-phenylimidazole-based S1P(1) receptor agonists that are accompanied by poor agonist activity at S1P(3). For instance, compound 20 displayed an EC(50)=4.7+/-1.3 nM at the S1P(1) receptor and EC(50)=780+/-1.3 nM at the S1P(3) receptor using a [gamma-(35)S]GTP-binding assay as compared to phospho-FTY720 (S1P(1) EC(50)=1.3+/-1.3nM, S1P(3) EC(50)=2.0+/-2.4 nM).
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Propilenoglicóis
/
Esfingosina
/
Benzimidazóis
/
Lisofosfolipídeos
/
Receptores de Lisoesfingolipídeo
/
Imunossupressores
Idioma:
En
Ano de publicação:
2005
Tipo de documento:
Article